Jawhar, M., Schwaab, J., Hausmann, D., Clemens, M. J., Naumann, N., Henzler, T., . . . Reiter, A. (2016). Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis. Leukemia, 30(12), . https://doi.org/10.1038/leu.2016.190
Chicago-Zitierstil (17. Ausg.)Jawhar, Mohamad, et al. "Splenomegaly, Elevated Alkaline Phosphatase and Mutations in the SRSF2/ASXL1/RUNX1 Gene Panel Are Strong Adverse Prognostic Markers in Patients with Systemic Mastocytosis." Leukemia 30, no. 12 (2016). https://doi.org/10.1038/leu.2016.190.
MLA-Zitierstil (9. Ausg.)Jawhar, Mohamad, et al. "Splenomegaly, Elevated Alkaline Phosphatase and Mutations in the SRSF2/ASXL1/RUNX1 Gene Panel Are Strong Adverse Prognostic Markers in Patients with Systemic Mastocytosis." Leukemia, vol. 30, no. 12, 2016, https://doi.org/10.1038/leu.2016.190.